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ARTICLE OPEN
Computer decision support systems for asthma:
a systematic review
Patricia Matui1, Jeremy C Wyatt2, Hilary Pinnock1, Aziz Sheikh1 and Susannah McLean1
BACKGROUND: Increasing use of electronic health records offers the potential to incorporate computer decision support systems
(CDSSs) to prompt evidence-based actions within routine consultations.
AIM: To synthesise the evidence for the use of CDSSs by professionals managing people with asthma.
MATERIALS AND METHODS: We systematically searched Medline, Embase, Health Technology Assessment, Cochrane and Inspec
databases (1990 to April 2012, no language restrictions) for trials, and four online repositories for unpublished studies. We also
wrote to authors. Eligible studies were randomised controlled trials of CDSSs supporting professional management of asthma.
Studies were appraised (Cochrane Risk of Bias Tool) and ﬁndings synthesised narratively.
RESULTS: A total of 5787 articles were screened, and eight trials were found eligible, with six at high risk of bias. Overall, CDSSs for
professionals were ineffective. Usage of the systems was generally low: in the only trial at low risk of bias the CDSS was not used at
all. When a CDSS was used, compliance with the advice offered was also low. However, if actually used, CDSSs could result in closer
guideline adherence (improve investigating, prescribing and issuing of action plans) and could improve some clinical outcomes.
The study at moderate risk of bias showed increased prescribing of inhaled steroids.
CONCLUSIONS: The current generation of CDSSs is unlikely to result in improvements in outcomes for patients with asthma
because they are rarely used and the advice is not followed. Future decision support systems need to align better with professional
workﬂows so that pertinent and timely advice is easily accessible within the consultation.
npj Primary Care Respiratory Medicine (2014) 24, Article number: 14005; doi:10.1038/npjpcrm.2014.5; published online 20 May 2014
INTRODUCTION
The Global Initiative for Asthma estimates that 300 million people
worldwide have asthma.1 Prevalence rates as high as 32% have
been recorded in the United Kingdom and Australia,2 and the
prevalence is increasing in many parts of the world.3–5 Despite
evidence-based guidelines,1,6–9 there is consistent evidence that
asthma is suboptimally controlled, resulting in unnecessary
morbidity, loss of school and workdays, and high costs for
countries.9–11 There are 250,000 asthma-related deaths each year.1
There are many reasons why guidelines are poorly implemen-
ted, including physician’s lack of knowledge or inertia of
practice.12,13 As electronic health records are now the norm in
many parts of the world,14,15 it is feasible to provide professionals
with computer decision support systems (CDSSs) to prompt
evidence-based actions within routine consultations, potentially
improving professional adherence to guidelines.
Our systematic review aimed to synthesise the evidence for the
use of CDSSs by professionals managing people with asthma. We
were primarily interested in the effectiveness of CDSSs in
improving patient outcomes, but also sought to investigate
process measures of guideline adherence and practical usage of
the system.
MATERIALS AND METHODS
Our protocol is registered with the PROSPERO international prospective
register of systematic reviews (CRD 42012002412). We followed the
methodology described in the Cochrane Handbook for Systematic Reviews
of Interventions.16
Inclusion criteria
We used the PICOS (Participants, Intervention, Comparator, Outcomes,
Study design) strategy for describing trials in which we were interested:
Participants. As this study is a review of the evidence, the study
participants were de facto the health professionals using CDSSs who
were caring for people with asthma—i.e., doctors, nurses and others
(e.g., physiotherapists).
Intervention. We adopted Wyatt et al.’s deﬁnition of CDSs as ’active
knowledge systems which use two or more items of patient data to
generate case-speciﬁc advice.’17 Haynes and Wilczynski similarly described
such systems as ‘information technology which matches characteristics of
individual patients to a computerised knowledge base’, with software
algorithms generating patient-speciﬁc information in the form of
recommendations.18 There are various levels of sophistication for CDSSs,
from reminders to enter speciﬁc data, prescribe certain drugs/vaccines or
provide an asthma action plan, to a system retrieving patient asthma
information from an electronic health-care record and providing a critique
on the intended clinical action. Systems were included if they used patient
data to generate case-speciﬁc asthma advice. Systems relating only to the
task of asthma diagnosis or those exclusively providing patients with
support for self-management were excluded.
Comparator. The comparator was ‘usual care’, speciﬁcally without the use
of a CDSS.
Outcomes. Our primary interest was in the impact of CDSSs on clinical
asthma control. In line with recommended guidelines,19 we included
outcomes that reﬂected current control (including asthma-related quality
of life) and frequency of asthma exacerbations (including frequency of the
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general practitioner’s asthma visits, emergency department asthma visits
and asthma hospitalisations).
We were also interested in the process by which CDSSs might impact
asthma control, both practical usage issues (e.g. the proportion of
professionals who actually used the CDSS, the numbers of alerts issued
and the impact on time within the consultation) as well as process
measures reﬂecting enhanced guideline adherence (e.g. changes in
treatment, in tests ordered and in the proportion of patients with asthma
action plans).
Study design. All reports of randomised controlled trials of CDSSs used by
health-care professionals for patients with asthma, in any language,
published and unpublished, were eligible for inclusion. No other study
designs were included.
Information sources and search strategy
We searched Medline, Embase, Cochrane Central Register of Controlled
Trials, Health Technology Assessment and Inspec (engineering) data-
bases from 1990 to April 2012 with the terms listed in Supplementary
Appendix 1. We wrote to experts and authors of all included studies
requesting additional relevant studies. We searched for ongoing and
unpublished trials on the following websites: https://portal.nihr.ac.uk/
Pages/NRRArchive.aspx, www.clinicaltrials.gov, www.controlled-trials.com
and www.anzctr.org.au.
Study selection
Two authors (PM and SM) independently screened titles and abstracts,
assessing them against the inclusion criteria. The full text of each
potentially eligible paper was reviewed by both authors to decide whether
the study should be included. Disagreements were resolved by discussion
and, if necessary, arbitration of a third researcher (HP, AS or JCW).
Data collection and abstraction
Using a piloted data extraction form, PM and SM independently extracted
the following data from included trials: country, setting, funding, study
design, health-care professionals, patient population, features of the CDSS
intervention, description of the control group, outcome measures and any
adverse effects. Extraction tables were compared, and discussed with a
third researcher (HP, AS or JW) arbitrating in the event of unresolved
disagreement.
Quality of reporting of trials
We assessed the risk of bias in each trial using the seven-criteria approach
described in the Cochrane Handbook for Systematic Reviews of
Interventions.16 Overall, each study was rated as follows: A: low risk of
bias—no bias found; B: moderate risk of bias—one criterion for risk of bias;
C: high risk of bias—more than one criterion for risk of bias.
Synthesis of results
We anticipated considerable heterogeneity in the populations studied, and
in the interventions and the outcomes reported in the trials precluding
meta-analysis of data. Instead, we planned to undertake a narrative
synthesis based on our theoretical model of how such computer systems
are expected to exert their effects (see Figure 1). The expectation is that, in
a linked causal chain, CDSSs will impact process outcomes, which, in turn,
will impact clinical outcomes. The theory underpinning their effectiveness
is that relevant reminders and recommendations during a consultation will
inﬂuence clinicians’ behaviour and thereby improve guideline adherence
as measured by process outcomes (e.g. more rational ordering of
investigations, prescribing of treatment and use of asthma action plans).
Implementation of evidence-based practices will consequently be
measureable in clinical outcomes for asthma patients, such as fewer
exacerbations, emergency department attendances and hospitalisations.
RESULTS
Study selection
Figure 2 is the PRISMA ﬂow diagram. From 5,787 titles, eight
studies were selected,20–27 seven in English and one in Spanish.26
One study had two reports.24,28 None of the experts we contacted
identiﬁed any additional eligible studies. We found nine ongoing
and eight unpublished trials (Supplementary Appendix 2).
We excluded a small group of studies from the early 1990s of
computerised theophylline dose calculators because they
addressed a speciﬁc problem in emergency care and have already
been evaluated in a Cochrane review.29
Study characteristics
See Table 1 for details of study characteristics. Most studies were
cluster randomised controlled trials20–26 in primary care in the
UK21,25 or the Netherlands.23,24 Two studies randomised practices
to receive a CDSS for asthma prescribing or a system for angina or
cholesterol prescribing.21,24 The practices providing data on
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Figure 1. Theoretical model showing how a computer decision support system can improve asthma outcomes.
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angina and cholesterol prescribing were unaware that their (usual
care) asthma prescribing data were control data for the parallel
asthma study.
Six of the systems were integrated into an electronic health
record:20,22–24,26,27 one was partly integrated21 and one was a
stand-alone system.25 Five of the studies20,21,23,26,27 explicitly
reported that the system gave prescribing advice and reminders.
One system concentrated solely on the prescribing of inﬂuenza
vaccine for ‘at-risk’ children.27 Four studies were based on asthma
management guidelines.21,25–27 One system included a complex
risk prediction algorithm,25 and one system ‘critiqued’ the doctor’s
intended management plan and made recommendations.23
Risk of bias within studies
Table 2 lists the quality assessment: most studies were rated at
high risk of bias. The study by Eccles et al.21 was rated at low risk
of bias and that by Martens et al.24 at moderate risk of bias.
Effectiveness of CDSSs
The impact of CDSS on process, usage and clinical outcomes is
detailed in Table 3. It was anticipated that usage and process
outcomes would inﬂuence clinical outcomes as reﬂected in our
model (Figure 1).
Practical aspects of CDSS use
In the study by Eccles et al.,21 the median number of activations of
the system per practice was zero. In that by Kuilboer et al.,23
10,863 visits generated 10,532 decision support comments,
but the doctor waited for the critique only 22% of the time,
and then read only a third of them. In Tierney et al.’s study,27
doctors complied with a third of the systems’ suggestions.
Bell et al.20 reported that the CDSS was used 70% of the time.
In the study by Fiks et al.,22 the vaccine alerts were only active
during 27% of visits.
Process outcomes
Changes in tests ordered. Eccles et al.,21 McCowan et al.25 and
Plaza et al.26 all reported that the systems made no difference in the
rates of ordering spirometry, X-rays, allergy tests or blood tests. Bell
et al.20 reported an increase in spirometry requests at intervention
practices from 15 to 24%, whereas there was a decrease at control
practices from 8 to 1%. In Kuilboer et al.,23 peak expiratory ﬂow rate
and spirometry tests were ordered more often in the intervention
group, in patients over 11 years of age. In a four-arm trial, Tierney
et al.27 reported that between 39 and 50% of patients received the
suggestion to obtain pulmonary function tests.
Changes in treatments. Eccles et al.,21 the only trial at low risk of
bias, found no difference in asthma-related prescribing as a result
of the intervention. Martens et al.24 demonstrated an increase in
the prescribing of inhaled corticosteroids to 44% of asthma
patients (95% conﬁdence interval (CI), 30–56%) in the intervention
group, compared with 27% (95% CI, 14–47%) in the control group.
In the trial by Bell et al.,20 there was a highly signiﬁcant
(P= 0.006) difference between the rate of prescribing inhaled
corticosteroids in the subgroup of urban intervention practices
compared with urban control practices. Urban and suburban
practices were analysed separately in the cluster controlled trial
because of marked baseline differences in patient population: the
urban practices had more severe asthma.
Kuilboer et al.23 demonstrated a signiﬁcant reduction in the
prescribing of cromoglyate in a post hoc analysis. Plaza et al.26
demonstrated a doubling of treatment conforming to guidelines,
from 18 to 34% (P= 0.02). Vaccination rates increased in both arms
of the Fiks trial with no signiﬁcant differences.22 McCowan et al.25
found no difference in asthma-related prescribing between the
trial arms due to the intervention. Tierney et al.27 reported on
treatment suggestions for both asthma and chronic obstructive
pulmonary disease. For example, across the four arms of the
Tierney trial, between 5 and 9% of patients received the suggest-
Medline
1,252
Embase
3,163
INSPEC
161
Health technology
assessment
52
Cochrane
1,398
6,026 titles
5,787 titles
41 titles
239 duplicates
deleted
5,745 titles excluded
by title and abstract
screening
8 Studies included
(described in 9 articles)
1 Study protocol only
15 not RCTs
10 not CDSSs
4 theophylline calculators
2 others
10 Ongoing or
unpublished trials from:
https://portal.nihr.ac.uk/
Pages/NRRArchive.aspx
and
www.clinicaltrials.gov,
www.controlled-
trials.com
www.anzctr.org.au
Figure 2. PRISMA ﬂow diagram.
Computer decision support systems for asthma
P Matui et al
3
© 2014 Primary Care Respiratory Society UK/Macmillan Publishers Limited npj Primary Care Respiratory Medicine (2014) 14005
Table 1. Characteristics of studies
Author (country) Study design Participants and setting Age
(years)
Time scale Intervention Control
Bell et al.20 (USA) Cluster RCT 12 clusters: 12 primary
care practices, 19,450
patients
0–18 12 months
6 months prior to
study start
clinicians
participated in an
educational
programme,
12 months of
intervention
CDSS embedded in an
electronic health record
(EHR) in the form of alerts
and reminders based on
expert asthma guidelines.
This included a data entry
tool, standardised
documentation for asthma
severity classiﬁcation,
standardised drug and
spirometry order sets and
an asthma control plan.
There was also an
educational programme for
professionals.
The control group
experienced educational
programme for
professionals. It also had
access to the data entry
and all documentation
tools but only passively,
without alerts and
reminders.
Eccles et al.21 (UK) Cluster RCT with
2 × 2 incomplete
block design
60 clusters: 60 primary
care practices, 1,129
patients
⩾ 18 24 months
12 months
baseline period,
12 months
intervention
CDSS offered suggestions
for management (including
prescribing) depending on
the chosen clinical scenario
and requested the entry of
relevant information.
Controls received
intervention for angina,
while the asthma
intervention group was
the control from the
angina group as a
strategy to balance the
Hawthorne effect.
Fiks et al.22 (USA) Cluster RCT 20 clusters: 20
practices, 6,110
patients
5–19 6 months
All intervention
CDSS was an EHR-based
inﬂuenza vaccination alert
system. Inﬂuenza vaccine
alerts appeared
prominently at the top of
the computer screen in
bold and highlighted text
whenever the electronic
health record was opened
for a study subject who was
due for this vaccine. Also a
link was provided to
simplify vaccine ordering.
Described as routine
care.
Kuilboer et al.23
(The Netherlands)
Cluster RCT 40 clusters: 32 primary
care practices with a
total of 40 GPs, each
control practice with a
mean of 4,933 control
and 4,865 intervention
patients
All 10 months
5 months baseline
period, 5 months
intervention
‘AsthmaCritic’, the CDSS,
relied solely on the existing
data in the EHR. Once data
related to the visit was
entered, the system
evaluated whether the
patient had asthma or
COPD, reviewed the
physician’s treatment of
asthma and COPD, and
generated feedback. In this
way, the doctor made the
decisions and the CDSS
‘critiqued’ these decisions.
Described as usual care.
Martens et al.24,28
(The Netherlands)
Cluster RCT with
an incomplete
block design
53 clusters, 14
practices with a
total of 53 GPs
All 12 months
6 months
intervention,
6 months data
collection
CDSS was part of a
computer-reminder system
integrated into the EHR as a
prescribing module. When
the GP prescribed a drug
the decision support
system was activated and
provided information
speciﬁc to the patient (e.g.,
age and gender) and the
prescribed drug. The GP
was obliged to enter a
diagnosis code which the
CDSS would check and use
to issue relevant reminders.
One group that received
prescription reminders
for cholesterol-lowering
drugs served as controls
for the other group that
received CDSS for
antibiotics, asthma and
COPD, and vice versa.
McCowan et al.25
(UK)
Cluster RCT 40 clusters: 40
practices, 477 patients
All 6 months
No baseline data
‘Asthma Crystal Byte’ was a
stand-alone decision
support system with
management guidelines
for asthma that aimed to
improve the quality of the
consultation. It included
risk prediction software
and printed asthma
management plans.
The control group had
no knowledge of the
intervention and had to
report parallel data on
the same number of
patients as were
recruited to the
intervention group.
Computer decision support systems for asthma
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ion to ‘start inhaled corticosteroids.’ However, only 11–30% of the
physicians or pharmacists complied with this suggestion.
Clinical outcomes
Asthma symptoms. Three studies reported asthma
symptoms.21,25,26 Eccles and coworkers30 reported that the CDSS
had no effect on the validated Newcastle Asthma Symptoms
Questionnaire (mean difference − 0.6 (95% CI, − 2.1 to 0.9)).21
Plaza et al.26 reported that asthma daytime symptoms, but
not night-time symptoms, were signiﬁcantly reduced in the
intervention group compared with the control group (Wilcoxon
Po0.02). McCowan et al.25 reported no signiﬁcant differences in
asthma symptoms between the intervention and control groups
(odds ratio 0.3, 95% CI, 0.03–3.3), although this study was
underpowered.
Asthma-related quality of life. Three studies reported asthma-
related quality of life.21,26,27 The study by Eccles et al.,21 a trial at
low risk of bias, reported no effect on the validated Asthma
Quality of Life Questionnaire.31 Plaza and coworkers32 reported
quality of life using the Spanish version of the St George’s
Respiratory Questionnaire and found signiﬁcant improvement in
all domains (activity P= 0.002, symptoms P= 0.003, impact
P= 0.001).26 Tierney et al.27used two different quality-of-life
scales,33,34 but found a signiﬁcant result only in one subdomain,
possibly due to multiple testing.
Frequency of asthma exacerbations. Two studies reported exacer-
bation rates. In the study by Plaza et al.,26 exacerbation rates were
not signiﬁcantly different between the control and intervention
groups: mean exacerbations, 1.3 (s.e.) = 1.2) in the control group
and 0.5 (s.e. = 0.3) in the intervention group (Wilcoxon P= 0.2).
McCowan et al.25 reported that in the intervention group 12/147
patients had exacerbations compared with 57/330 in the control
group: control patients were approximately twice as likely to
experience an exacerbation as were intervention patients (odds
ratio 0.4, 95% CI, 0.2–0.9, after adjustment for clustering). The
denominators were different because of study dropouts.
Unscheduled health-care utilisation. McCowan et al.25 reported
signiﬁcantly fewer unscheduled general practitioner consultations
in the intervention group in comparison with the control group
(odds ratio 0.6, 95% CI, 0.4–0.95). Four studies reported no
differences in the frequency of asthma-related visits to the general
practitioner.20,22,23,26
Two studies reported no signiﬁcant difference between the
intervention and control groups in emergency department visits
or hospitalisations.25,27 The absolute numbers were close to zero.
Table. 1. (Continued )
Author (country) Study design Participants and setting Age
(years)
Time scale Intervention Control
Plaza et al.26
(Spain)
Cluster RCT 20 clusters: 10
pulmonologists and
10 GPs, 198 patients
⩾ 14 12 months
6 months baseline
and 2 sessions of
educational
programme for
clinicians,
12 months
intervention
CDSS providing patient-
tailored recommendations
based on the GINA
guidelines enabled
clinicians to establish the
severity of asthma
according to the GINA
classiﬁcation, from relevant
inputs such as PEFR,
symptom frequency,
quantity of corticosteroids
and the clinician’s
professional opinion. Then
the CDSS would
recommend medications
according to the GINA
guidelines. There were also
education programmes for
clinician and patients,
teaching inhaler technique
and general information
about the condition of
asthma.
The control group
worked as normal but
recorded additional data
for comparison.
Tierney et al.27
(USA)
2 × 2 factorial
randomisation of
patients
4 clusters: 4 hospital-
based academic
practices with 25
faculty general
internists and over 100
internal medicine
residents, 1 full-time
and 9 part-time
pharmacists, 706
patients
⩾ 18 36 months
28 months
recruitment and
baseline,
8 months
intervention
CDSS generated care
suggestions based on
agreed guidelines. These
include performing
pulmonary function tests,
giving inﬂuenza and
pneumococcal
vaccinations, prescribing
advice and encouraging
smoking cessation. These
suggestions were
presented on doctors’
workstations or were
printed under a list of
active medications that
doctors received along with
the patient’s paper chart
when he/she presented for
usual care.
Care suggestions were
still generated by the
CDSS but were not
displayed to the
physician or pharmacists
caring for patients in the
control group.
Abbreviations: CDSS, computer decision support system; COPD, chronic obstructive pulmonary disease; GINA, The Global Initiative for Asthma; GP, general
practitioner; RCT, randomised controlled trial.
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DISCUSSION
Main ﬁndings
We found eight relevant trials, four of which reported clinical
measures of asthma control.21,25–27 The key ﬁnding was that CDSSs
for health-care professionals were ineffective in improving patient
outcomes because the systems were rarely used,21–23 and there was
low compliance with the advice when it was issued.23,27 However,
when systems are used, clinical outcomes can improve.20,25
Strengths and limitations of this study
A strength of this review is its robust search strategy. We used the
Cochrane-suggested terminology for asthma and randomised
controlled trials, and drew on our eHealth research group’s
inclusive search terms for CDSS.35 Nevertheless, we may have
missed some relevant studies, and the list of ongoing trials
suggests that more evidence may be available in due course.
In contrast to the methodology used by the recent McMaster
group series of reviews in which improvement was considered to
have occurred if >50% of the selected outcomes showed
beneﬁt,18,36–41 we report speciﬁc clinical, usage and process
outcomes from each trial to explain why the systems were having
an effect or not.
We did not perform a meta-analysis as populations and
outcomes across trials were too heterogeneous. Descriptions of
interventions were often poorly described, which may have
limited our interpretation of the ﬁndings.
Interpretation of ﬁndings in relation to previously published work
Our review focuses on asthma as a clinically important area for
CDSSs. A crucial observation was that the systems were rarely
used.13,21,42 Usage was not considered in the recent McMaster
group’s meta-regression,43 although this is clearly fundamental to
understanding the reasons for lack of effect, and should be a
crucial focus for development if systems are to improve patient
outcomes above the 15–31% impact on outcomes reported by the
McMaster group in a series of reviews.36–41 Usage rate of the
systems should be a core standard for reporting trials of CDSSs.
The McMaster group’s meta-regression explored the features of
CDSSs associated with system ‘effectiveness’. They found
(1) stand-alone programs, (2) advice directed at both health-care
practitioners and patients, (3) requiring users to enter an
explanation for any overrides of system recommendations and
(4) developers’ involvement in trials to be associated with better
patient outcomes. Poor integration (as in a stand-alone program),
however, risks clinicians avoiding using the system as in Eccles
et al.21 The issue, however, is complex as advice presented at the
time of care does not always predict success, possibly because
practitioners become overwhelmed by such integrated alerts that
interrupt their workﬂow.43
Our recent analysis of recordings of general practice consulta-
tions emphasised the importance of the timing of alerts in the
context of prescribing safety CDSSs.44 The practitioner, negotiat-
ing with the patient, makes decisions regarding drugs and
management throughout the consultation when information
about allergies, sensitivities, interactions and guideline recom-
mendations might be useful. Provision of information during the
ﬁnal computer-based task of generating the prescription can
frustrate clinicians, who then override the alerts. Integration with
workﬂow requires a detailed study of the consultation process.
Implications for future research, policy and practice
A detailed description of the CDSS intervention under investiga-
tion is essential to providing insight into what promotes a well-
used and effective system that can inform future development.
Taxonomies and frameworks such as those described by
Kawamoto et al.,45 Garg et al.46 or Berlin et al.47 may provide a
suitable basis for a full description. Future research should
substantiate our theoretical model (Figure 1), which we suggest
as a possible useful framework. In terms of the logical chain from
usage to process outcomes to clinical outcomes, Bell et al.20
demonstrated that usage rates have an impact on process
outcomes, and Plaza et al.26 demonstrated the impact of process
outcomes on health outcomes. However, we feel that further
research is required to evidence this model more thoroughly.
Conclusions
Our review suggests that current CDSSs are unlikely to result in
improved outcomes in asthma because they are rarely used and
the advice not followed. A key challenge in the future design of
decision support systems lies in the better integration and
alignment with professional workﬂows such that they are adopted
into routine practice.
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